Shares of Pacific Biosciences of California slid by a staggering 31.68% in 30 days from $39.92 to $27.27 at 20:23 EST on Monday, after three consecutive sessions in a row of losses. NASDAQ Composite is sliding 0.48% to $13,895.12, after two consecutive sessions in a row of losses.

Pacific Biosciences of California’s last close was $29.85, 96.88% below its 52-week high of $53.69.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 74.5% for the current quarter and 71.5% for the next. The company’s growth estimates for the current quarter and the next is a negative 33.3% and a negative 50%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 92.29M for the twelve trailing months.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $27.27 at 20:23 EST, way under its 52-week high of $53.69 and way above its 52-week low of $2.66.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way under its 50-day moving average of $33.94 and way higher than its 200-day moving average of $24.72.

More news about Pacific Biosciences of California.

LEAVE A REPLY

Please enter your comment!
Please enter your name here